Repositorio Dspace

Effectiveness of Consumption of a Combination of Citrus Fruit Flavonoids and Olive Leaf Polyphenols to Reduce Oxidation of Low-Density Lipoprotein in Treatment-Naive Cardiovascular Risk Subjects: A Randomized Double-Blind Controlled Study

Mostrar el registro sencillo del ítem

dc.contributor.author Victoria-Montesinos, Desiree
dc.contributor.author Abellán-Ruiz, María-Salud
dc.contributor.author Luque-Rubia, Antonio-Jesús
dc.contributor.author Guillén-Martínez, Daniel
dc.contributor.author Pérez-Piñero, Silvia
dc.contributor.author Sánchez-Macarro, Maravillas
dc.contributor.author García-Muñoz, Ana-María
dc.contributor.author Cánovas-García, Fernando
dc.contributor.author Castillo-Sánchez, Julián
dc.contributor.author López-Román, Francisco-Javier
dc.date.accessioned 2025-11-24T12:24:00Z
dc.date.available 2025-11-24T12:24:00Z
dc.date.issued 2021-04
dc.identifier.citation Victoria-Montesinos D, Abellán Ruiz MS, Luque Rubia AJ, Guillén Martínez D, Pérez-Piñero S, Sánchez Macarro M, et al. Effectiveness of Consumption of a Combination of Citrus Fruit Flavonoids and Olive Leaf Polyphenols to Reduce Oxidation of Low-Density Lipoprotein in Treatment-Naïve Cardiovascular Risk Subjects: A Randomized Double-Blind Controlled Study. Antioxidants. 11 de abril de 2021;10(4):589.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22146
dc.description.abstract The aim of the study was to assess whether oral intake of a nutraceutical product (Citrolive?) could determine changes in low-density lipoprotein (LDL) oxidation and other parameters of lipid metabolism and plasma atherogenic capacity. Citrolive? is a commercial extract obtained from the combination of citrus fruit flavonoids and olive leaf extracts. Twenty-three untreated subjects (69.6% males, 30.4% females, mean age 41.9 ± 9.4 years) with cardiovascular risk factors and a total cholesterol level >200 mg/dL and LDL cholesterol (LDL-C) > 130 mg/dL participated in a 3-month randomized double-blind controlled study. Participants in the intervention group (71.4% males, 28.6% females, mean age 42.7 ± 9.7 years) consumed Citrolive? (500 mg, two capsules/day), and controls (66.7% males, 33.3% females, mean age 40.6 ± 9.4 years) received a matched placebo. At 3 months, oxidized LDL (ox-LDL) decreased significantly in the intervention group from 93.8 ± 19.1 U/L to 62.8 ± 28.7 U/L (p < 0.05), whereas the control group increased from 98.2 ± 23.5 U/L to 105.7 ± 21.9 U/L (p = 0.1). Between-group differences were also significant (p < 0.05). Similar findings in the ox-LDL/LDL-C ratio were observed. Serum paraoxonase activity (PON1) increased significantly in the intervention group from 64.5 ± 15.6 U/L to 78.7 ± 28.8 U/L (p < 0.05) but remained unchanged in controls. Consumption of Citrolive? for 3 months in treatment-naïve subjects with moderate risk of atherosclerosis was associated with a reduction in oxidized LDL-C and LDL-oxidase/LDL-C ratio as compared to controls.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/ *
dc.title Effectiveness of Consumption of a Combination of Citrus Fruit Flavonoids and Olive Leaf Polyphenols to Reduce Oxidation of Low-Density Lipoprotein in Treatment-Naive Cardiovascular Risk Subjects: A Randomized Double-Blind Controlled Study
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 33920476
dc.relation.publisherversion https://www.mdpi.com/2076-3921/10/4/589
dc.identifier.doi 10.3390/antiox10040589
dc.journal.title Antioxidants
dc.identifier.essn 2076-3921


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta